Charts
|
IMU Biotech |
Re:
IMUGENE CHART. TA only
|
|
slambo
|
31K |
15M |
0 |
18/04/24 |
18/04/24 |
Charts
|
31K
|
15M
|
0
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Proposed issue of securities - OCC
|
|
slambo
|
3 |
757 |
2 |
15/01/24 |
15/01/24 |
ASX - By Stock
|
3
|
757
|
2
|
|
ASX - By Stock
|
ALC |
Re:
Ann: AGM Chair Address
|
|
slambo
|
4 |
1.6K |
0 |
20/11/23 |
20/11/23 |
ASX - By Stock
|
4
|
1.6K
|
0
|
|
ASX - By Stock
|
ALC |
Re:
Ann: AGM Chair Address
|
|
slambo
|
4 |
1.6K |
1 |
20/11/23 |
20/11/23 |
ASX - By Stock
|
4
|
1.6K
|
1
|
|
ASX - By Stock
|
IPD |
Re:
Ann: ImpediMed announces leadership and Board changes
|
|
slambo
|
85 |
23K |
11 |
20/11/23 |
20/11/23 |
ASX - By Stock
|
85
|
23K
|
11
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Successful OrthoATI clinical trial
|
|
slambo
|
47 |
11K |
3 |
14/11/23 |
14/11/23 |
ASX - By Stock
|
47
|
11K
|
3
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Successful OrthoATI clinical trial
|
|
slambo
|
47 |
11K |
0 |
14/11/23 |
14/11/23 |
ASX - By Stock
|
47
|
11K
|
0
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
slambo
|
20K |
7.0M |
5 |
13/11/23 |
13/11/23 |
ASX - By Stock
|
20K
|
7.0M
|
5
|
|
ASX - By Stock
|
ALC |
Re:
Ann: Quarterly Activities Report & Placement Announcement/App 4C
|
|
slambo
|
74 |
28K |
4 |
08/11/23 |
08/11/23 |
ASX - By Stock
|
74
|
28K
|
4
|
|
ASX - By Stock
|
HMD |
Re:
HMD General Discussion
|
|
slambo
|
236 |
352K |
3 |
27/10/23 |
27/10/23 |
ASX - By Stock
|
236
|
352K
|
3
|
|
ASX - By Stock
|
PNV |
Re:
PNV - Banter and General Comments
|
|
slambo
|
11K |
5.9M |
9 |
27/10/23 |
27/10/23 |
ASX - By Stock
|
11K
|
5.9M
|
9
|
|
ASX - By Stock
|
PNV |
Re:
PNV - Banter and General Comments
|
|
slambo
|
11K |
5.9M |
10 |
26/10/23 |
26/10/23 |
ASX - By Stock
|
11K
|
5.9M
|
10
|
|
ASX - By Stock
|
OCC |
Re:
OCC Trading
|
|
slambo
|
1.6K |
468K |
1 |
25/10/23 |
25/10/23 |
ASX - By Stock
|
1.6K
|
468K
|
1
|
|
ASX - By Stock
|
PNV |
Re:
PNV - Banter and General Comments
|
|
slambo
|
11K |
5.9M |
13 |
25/10/23 |
25/10/23 |
ASX - By Stock
|
11K
|
5.9M
|
13
|
|
ASX - By Stock
|
IPD |
Re:
Ann: Quarterly Results and Investor Conference Call
|
|
slambo
|
8 |
3.0K |
3 |
24/10/23 |
24/10/23 |
ASX - By Stock
|
8
|
3.0K
|
3
|
|
Charts
|
IPD |
Re:
IPD chart
|
|
slambo
|
816 |
342K |
14 |
18/10/23 |
18/10/23 |
Charts
|
816
|
342K
|
14
|
|
Charts
|
IPD |
Re:
IPD chart
|
|
slambo
|
816 |
342K |
9 |
13/10/23 |
13/10/23 |
Charts
|
816
|
342K
|
9
|
|
ASX - By Stock
|
IPD |
Re:
Ann: ImpediMed Announces Appointment of Chief Medical Officer
|
|
slambo
|
26 |
5.3K |
8 |
27/09/23 |
27/09/23 |
ASX - By Stock
|
26
|
5.3K
|
8
|
|
ASX - By Stock
|
IPD |
Re:
Ann: Proxy Advisers Recommend Voting AGAINST All Resolutions
|
|
slambo
|
100 |
29K |
4 |
22/09/23 |
22/09/23 |
ASX - By Stock
|
100
|
29K
|
4
|
|
ASX - By Stock
|
IPD |
Re:
Ann: Proxy Advisers Recommend Voting AGAINST All Resolutions
|
|
slambo
|
100 |
29K |
2 |
20/09/23 |
20/09/23 |
ASX - By Stock
|
100
|
29K
|
2
|
|
ASX - By Stock
|
IPD |
Re:
Ann: Proxy Advisers Recommend Voting AGAINST All Resolutions
|
|
slambo
|
100 |
29K |
6 |
20/09/23 |
20/09/23 |
ASX - By Stock
|
100
|
29K
|
6
|
|
ASX - By Stock
|
IPD |
Re:
Ann: Shareholder Conference Call
|
|
slambo
|
44 |
13K |
13 |
11/09/23 |
11/09/23 |
ASX - By Stock
|
44
|
13K
|
13
|
|
ASX - By Stock
|
IPD |
Re:
Ann: Shareholder Update on Section 249D Notice & Company Position
|
|
slambo
|
101 |
27K |
7 |
08/09/23 |
08/09/23 |
ASX - By Stock
|
101
|
27K
|
7
|
|
ASX - By Stock
|
EBR |
Re:
Ann: Positive Results from the SOLVE-CRT Randomised Sub-Study
|
|
slambo
|
34 |
6.4K |
1 |
04/09/23 |
04/09/23 |
ASX - By Stock
|
34
|
6.4K
|
1
|
|
ASX - By Stock
|
IPD |
Re:
Ann: Shareholder Update on Section 249D Notice & Company Position
|
|
slambo
|
101 |
27K |
2 |
04/09/23 |
04/09/23 |
ASX - By Stock
|
101
|
27K
|
2
|
|
ASX - By Stock
|
IPD |
Re:
Ann: Shareholder Update on Section 249D Notice & Company Position
|
|
slambo
|
101 |
27K |
2 |
04/09/23 |
04/09/23 |
ASX - By Stock
|
101
|
27K
|
2
|
|
ASX - By Stock
|
PNV |
Re:
PNV - Banter and General Comments
|
|
slambo
|
11K |
5.9M |
12 |
03/09/23 |
03/09/23 |
ASX - By Stock
|
11K
|
5.9M
|
12
|
|
ASX - By Stock
|
IPD |
Re:
Ann: Response to Notice 249D from IPDs Executive Leadership Team
|
|
slambo
|
29 |
7.2K |
3 |
30/08/23 |
30/08/23 |
ASX - By Stock
|
29
|
7.2K
|
3
|
|
ASX - By Stock
|
IPD |
Re:
Ann: Response to Notice 249D from IPDs Executive Leadership Team
|
|
slambo
|
29 |
7.2K |
7 |
30/08/23 |
30/08/23 |
ASX - By Stock
|
29
|
7.2K
|
7
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene completes $35M Placement & Launches c.$30M SPP
|
|
slambo
|
454 |
174K |
3 |
25/08/23 |
25/08/23 |
ASX - By Stock
|
454
|
174K
|
3
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene completes $35M Placement & Launches c.$30M SPP
|
|
slambo
|
454 |
174K |
6 |
25/08/23 |
25/08/23 |
ASX - By Stock
|
454
|
174K
|
6
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Investor Webinar on Acquisition of License for Azer-cel
|
|
slambo
|
335 |
119K |
3 |
21/08/23 |
21/08/23 |
ASX - By Stock
|
335
|
119K
|
3
|
|
ASX - By Stock
|
4DX |
Re:
4DX Chart
|
|
slambo
|
730 |
324K |
6 |
21/08/23 |
21/08/23 |
ASX - By Stock
|
730
|
324K
|
6
|
|
ASX - By Stock
|
PER |
Re:
James Garner AKA JG
|
|
slambo
|
190 |
49K |
3 |
20/08/23 |
20/08/23 |
ASX - By Stock
|
190
|
49K
|
3
|
|
ASX - By Stock
|
IPD |
Re:
Ann: Response to Notice received under s249D of Corporations Act
|
|
slambo
|
85 |
19K |
4 |
17/08/23 |
17/08/23 |
ASX - By Stock
|
85
|
19K
|
4
|
|
ASX - By Stock
|
IPD |
Re:
Ann: Response to Notice received under s249D of Corporations Act
|
|
slambo
|
85 |
19K |
10 |
17/08/23 |
17/08/23 |
ASX - By Stock
|
85
|
19K
|
10
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Chimeric to receive A$4.4 million introduction fee
|
|
slambo
|
25 |
10K |
5 |
16/08/23 |
16/08/23 |
ASX - By Stock
|
25
|
10K
|
5
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Notice of Extraordinary General Meeting/Proxy Form
|
|
slambo
|
11 |
2.7K |
3 |
15/08/23 |
15/08/23 |
ASX - By Stock
|
11
|
2.7K
|
3
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
slambo
|
9.9K |
4.4M |
6 |
08/08/23 |
08/08/23 |
ASX - By Stock
|
9.9K
|
4.4M
|
6
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
slambo
|
9.9K |
4.4M |
14 |
07/08/23 |
07/08/23 |
ASX - By Stock
|
9.9K
|
4.4M
|
14
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
slambo
|
9.9K |
4.4M |
11 |
07/08/23 |
07/08/23 |
ASX - By Stock
|
9.9K
|
4.4M
|
11
|
|
ASX - By Stock
|
4DX |
Re:
Research
|
|
slambo
|
2.4K |
1.0M |
1 |
04/08/23 |
04/08/23 |
ASX - By Stock
|
2.4K
|
1.0M
|
1
|
|
ASX - By Stock
|
TLX |
Re:
TLX Chart
|
|
slambo
|
1.5K |
561K |
5 |
04/08/23 |
04/08/23 |
ASX - By Stock
|
1.5K
|
561K
|
5
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
slambo
|
9.9K |
4.4M |
0 |
02/08/23 |
02/08/23 |
ASX - By Stock
|
9.9K
|
4.4M
|
0
|
|
ASX - By Stock
|
IPD |
Re:
Ann: Becoming a substantial holder
|
|
slambo
|
23 |
7.9K |
1 |
02/08/23 |
02/08/23 |
ASX - By Stock
|
23
|
7.9K
|
1
|
|
ASX - By Stock
|
PTX |
Re:
Ann: June 2023 Quarterly Update and Appendix 4C
|
|
slambo
|
45 |
17K |
11 |
27/07/23 |
27/07/23 |
ASX - By Stock
|
45
|
17K
|
11
|
|
ASX - By Stock
|
OPT |
Re:
Ann: OPT Announces Sozinibercept as the Drug Name for OPT 302
|
|
slambo
|
3 |
1.6K |
3 |
27/07/23 |
27/07/23 |
ASX - By Stock
|
3
|
1.6K
|
3
|
|
ASX - By Stock
|
PNV |
Re:
PNV - Banter and General Comments
|
|
slambo
|
11K |
5.9M |
6 |
11/07/23 |
11/07/23 |
ASX - By Stock
|
11K
|
5.9M
|
6
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Director Resignations and Appointment of Non-Executive Chair
|
|
slambo
|
77 |
20K |
2 |
10/07/23 |
10/07/23 |
ASX - By Stock
|
77
|
20K
|
2
|
|
ASX - By Stock
|
AVH |
Re:
Ann: AVITA Medical Receives FDA Approval for Full-Thickness Skin
|
|
slambo
|
127 |
41K |
3 |
27/06/23 |
27/06/23 |
ASX - By Stock
|
127
|
41K
|
3
|
|